Artificial Intelligence in Pharma Manufacturing Market: By Offering, By Technology, By Deployment Mode and Geography

Artificial Intelligence in Pharma Manufacturing Market Size, Share, Growth, Trends, and Global Industry Analysis: By Offering (Hardware, Software, Services), By Technology (Computer Vision, Computer Vision, Machine Learning, Natural Language Processing, Context-Aware Computing), By Deployment Mode (Cloud, On-Premise) and Region

Artificial Intelligence in Pharma Manufacturing Market size is valued at US$ 3.09 billion in 2023 and is poised to grow at a CAGR of 41.8% from 2024-2030. The global market provides a detailed overview of the market that can be segmented by offering, technology, and deployment mode. By offering, this market has been segmented into hardware, software, and services. The hardware segment is likely to be the largest and fastest-growing segment in the market. Based on technology, this market is segmented into computer vision, machine learning, natural language processing, and context-aware computing. Among these, the computer vision segment is expected to have the fastest-growing market during the forecast period. Based on deployment type, this market is segmented into cloud and on-premises. The cloud segment accounts for the largest share in 2022. The on-premises segment has the second-largest share during the forecast period.

Artificial Intelligence In Pharma Manufacturing Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

41.8%

Largest Market

Asia-Pacific

Fastest Growing Market

North America

Artificial Intelligence in Pharma Manufacturing Market Dynamics

Artificial intelligence (AI) is being more widely used in clinical trials research, which is driving up demand for AI in the pharmaceutical industry. It takes an average of 10-15 years to bring a new medicine to market, with half of that time spent in the clinical trial stages of the drug development cycle. As a result, employing AI models and analytics tools to speed up clinical trial phases, illness perception, identify relevant patients and important investigators to influence site selection, and enable novel clinical study designs is possible.

Artificial Intelligence In Pharma Manufacturing Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 3.09 billion

Market CAGR

41.8%

By Offering

  • Hardware
  • Software
  • Services

By Technology

  • Computer Vision
  • Computer Vision
  • Machine Learning
  • Natural Language Processing
  • Context-Aware Computing

By Deployment Mode

  • Cloud
  • On-Premise

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Download Free Sample Report

Frequently Asked Questions

Artificial intelligence in pharma manufacturing market size was valued at US$ 3.09 billion in 2023 and anticipated to rise at a CAGR of 41.8% over 2024-2030.

The major players in the global artificial intelligence in pharma manufacturing market are IBM (US), Microsoft (US), Google Inc (US), Intel (US), NVIDIA (US), Samsung Electronics (South Korea), Xilinx (US), Micron Technology (US), Salesforce (US), SAS (US), SAP SE (Germany), Facebook (US), Baidu (China), Oracle (US), General Electric (US), Amazon Web Services (US), Cisco (US), Rockwell Automation (US), Siemens (Germany) and Graphcore (UK).

North America is the fastest-growing region for Artificial Intelligence in Pharma Manufacturing Market

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Global Artificial Intelligence in Pharma Manufacturing Market Introduction
2.1. Global Artificial Intelligence in Pharma Manufacturing Market Taxonomy
2.2. Global Artificial Intelligence in Pharma Manufacturing Market Definitions
2.2.1. By Offering
2.2.2. By Technology
2.2.3. By Deployment Mode
3. Global Artificial Intelligence in Pharma Manufacturing Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Artificial Intelligence in Pharma Manufacturing Market Dynamic Factors - Impact Analysis
3.6. Global Artificial Intelligence in Pharma Manufacturing Market Competition Landscape
4. Global Artificial Intelligence in Pharma Manufacturing Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Artificial Intelligence in Pharma Manufacturing Market, By Offering, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) 
5.1. Hardware
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Software
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Services
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. Global Artificial Intelligence in Pharma Manufacturing Market Forecast, By Technology, 2019 - 2023 and Forecast, 2024 - 2030
6.1. Computer Vision
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Machine Learning
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Natural Language Processing
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Context-Aware Computing
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
7. Global Artificial Intelligence in Pharma Manufacturing Market Forecast, By Deployment Mode, 2019 - 2023 and Forecast, 2024 - 2030
7.1. Cloud
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. On-Premise
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
8. Global Artificial Intelligence in Pharma Manufacturing Market Forecast, By Region, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) 
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Artificial Intelligence in Pharma Manufacturing Market - Opportunity Analysis Index, By Offering, By Technology, By Deployment, and Region, 2024 - 2030
9. North America Artificial Intelligence in Pharma Manufacturing Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) 
9.1. Offering Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Hardware
9.1.2. Software
9.1.3. Services
9.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.2.1. Computer Vision
9.2.2. Machine Learning
9.2.3. Natural Language Processing
9.2.4. Context-Aware Computing
9.3. Deployment Mode Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.3.1. Cloud
9.3.2. On-Premise
9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. USA
9.4.2. Canada
9.5. North America Artificial Intelligence in Pharma Manufacturing Market - Opportunity Analysis Index, By Offering, By Technology, By End-Use and Country, 2024 - 2030
9.6. North America Artificial Intelligence in Pharma Manufacturing Market Dynamics Trends
10. Europe Artificial Intelligence in Pharma Manufacturing Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) 
10.1. Offering Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Hardware
10.1.2. Software
10.1.3. Services
10.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Computer Vision
10.2.2. Machine Learning
10.2.3. Natural Language Processing
10.2.4. Context-Aware Computing
10.3. Deployment Mode Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Cloud
10.3.2. On-Premise
10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Russia
10.4.7. Poland
10.4.8. Rest of Europe
10.5. Europe Artificial Intelligence in Pharma Manufacturing Market - Opportunity Analysis Index, By Offering, By Technology, By End-Use and Country, 2024 - 2030
10.6. Europe Artificial Intelligence in Pharma Manufacturing Market Dynamics Trends
11. Asia-Pacific Artificial Intelligence in Pharma Manufacturing Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) 
11.1. Offering Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Hardware
11.1.2. Software
11.1.3. Services
11.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Computer Vision
11.2.2. Machine Learning
11.2.3. Natural Language Processing
11.2.4. Context-Aware Computing
11.3. Deployment Mode Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Cloud
11.3.2. On-Premise
11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. ASEAN
11.4.5. Australia & New Zealand
11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific Artificial Intelligence in Pharma Manufacturing Market - Opportunity Analysis Index, By Offering, By Technology, By End-Use and Country, 2024 - 2030
11.6. Asia-Pacific Artificial Intelligence in Pharma Manufacturing Market Dynamics Trends
12. Latin America Artificial Intelligence in Pharma Manufacturing Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) 
12.1. Offering Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Hardware
12.1.2. Software
12.1.3. Services
12.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Computer Vision
12.2.2. Machine Learning
12.2.3. Natural Language Processing
12.2.4. Context-Aware Computing
12.3. Deployment Mode Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Cloud
12.3.2. On-Premise
12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Argentina
12.4.4. Rest of Latin America
12.5. Latin America Artificial Intelligence in Pharma Manufacturing Market - Opportunity Analysis Index, By Offering, By Technology, By End-Use and Country, 2024 - 2030
12.6. Latin America Artificial Intelligence in Pharma Manufacturing Market Dynamics Trends
13. Middle East and Africa Artificial Intelligence in Pharma Manufacturing Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) 
13.1. Offering Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Hardware
13.1.2. Software
13.1.3. Services
13.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Computer Vision
13.2.2. Machine Learning
13.2.3. Natural Language Processing
13.2.4. Context-Aware Computing
13.3. Deployment Mode Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Cloud
13.3.2. On-Premise
13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.4.1. Gulf Cooperation Council (GCC) Countries
13.4.2. Israel
13.4.3. South Africa
13.4.4. Rest of MEA
13.5. MEA Artificial Intelligence in Pharma Manufacturing Market - Opportunity Analysis Index, By Offering, By Technology, By End-Use and Country, 2024 - 2030
13.6. MEA Artificial Intelligence in Pharma Manufacturing Market Dynamics Trends
14. Competition Landscape 
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Feedstock Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. IBM (US)
14.2.2. Microsoft (US)
14.2.3. Google Inc (US)
14.2.4. Intel (US)
14.2.5. NVIDIA (US)
14.2.6. Samsung Electronics (South Korea)
14.2.7. Xilinx (US)
14.2.8. Micron Technology (US)
14.2.9. Salesforce (US)
14.2.10. SAS (US)
14.2.11. SAP SE (Germany)
14.2.12. Facebook (US)
14.2.13. Baidu (China)
14.2.14. Oracle (US)
14.2.15. General Electric (US)
14.2.16. Amazon Web Services (US)
14.2.17. Cisco (US)
14.2.18. Rockwell Automation (US)
14.2.19. Siemens (Germany)
14.2.20. Graphcore(UK)
15. Research Methodology
16. Key Assumptions and Acronyms

Key Market Players

  • IBM (US)
  • Microsoft (US)
  • Google Inc (US)
  • Intel (US)
  • NVIDIA (US)
  • Samsung Electronics (South Korea)
  • Xilinx (US)
  • Micron Technology (US)
  • Salesforce (US)
  • SAS (US)
  • SAP SE (Germany)
  • Facebook (US)
  • Baidu (China)
  • Oracle (US)
  • General Electric (US)
  • Amazon Web Services (US)
  • Cisco (US)
  • Rockwell Automation (US)
  • Siemens (Germany)
  • Graphcore(UK)

Related Industry Reports